A promising depression drug works. Psychedelics are back.
Just as top Trump administration health officials have begun to show a more receptive attitude to psychedelics, atai Life Sciences and Beckley Psytech said Tuesday that patients with difficult-to-treat depression symptoms who took Beckley's drug BPL-003 saw improvement in an eight-week trial. Atai is in the process of acquiring Beckley.
Patients on a higher dose of BPL-003 had an average decrease of 11.5 points on a rating scale that tracks depression symptoms. That compared with a 5.8 point drop among patients in the control group, who received a tiny dose of BPL-003.
The companies will need to continue testing BPL-003. But analysts said Tuesday that based on the results, they see the drug eventually hitting $1 billion in annual sales. 'The dataset should instill confidence in a $1B+ drug," Jefferies analyst Andrew Tsai wrote in a research note.
Atai shares were up 24% at midday. Shares of other biotechs working on psychedelic drugs took off as well: Compass Pathwards climbed 13%, while shares of MindMed were up 5.4%.
The Beckley drug, BPL-003, is a nasal spray version of the psychedelic 5-MeO-DMT, a close relation to DMT and other similar psychedelics.
A long list of biotechs have been looking toward psychedelic medicines in recent years. The aim is to find ways to treat neurological conditions like depression and post-traumatic stress disorder that have proven hard to cure with existing medicines.
None have been approved by the Food and Drug Administration so far, though in 2019, Johnson & Johnson received FDA permission to sell a depression medicine called Spravato, which is a derivative of the dissociative anesthetic ketamine.
The field hit a major roadblock last summer, when the FDA rejected an application from a private company called Lykos Therapeutics for approval of a treatment protocol for PTSD that combined use of the drug MDMA with talk therapy.
At the time, analysts said that other psychedelic treatments might be easier to get approved than Lykos's MDMA treatment, for reasons having to do with the specifics of the Lykos protocol.
Now, the positive data from atai and Beckley's drug comes as attitudes within the FDA appear to be shifting in favor of psychedelics. In an interview with the reality show fitness expert Jilian Michaels on NewsNation last month, FDA Commissioner Dr. Marty Makary suggested he was very open to approving psychedelic therapies.
'When I listen to the individuals who have tried some of these for real medical conditions – post-traumatic stress disorder, severe refractory depression – people tell me that they believe that psilocybin was successful, was curative, or significantly helped their severe mood disorder," Makary said. 'I'm saying we have to listen to doctors who have these experiences. And this is one of our top priorities at FDA: To listen to doctors, to listen to patients."
Those comments, and similar rhetoric from Robert F. Kennedy Jr., the U.S. health secretary, point to a potentially friendly attitude among regulators toward BPL-003 and similar medicines.
In the results announced Tuesday, atai and Beckley said that the two higher dose levels of BPL-003 they tested led to 'statistically significant improvements" in depression symptoms as soon as one day after treatment.
The companies said that patients were ready to leave the treatment center two hours after receiving the medication on average. Atai noted that patients who take Johnson & Johnson's Spravato need to stay at their doctor's office for two hours after taking the medicine, which sets a precedent for a similar protocol.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
10 hours ago
- Mint
Listeria risk outbreak: FDA sounds alarm, recalls tainted blueberries
The U.S. Food and Drug Administration (FDA) has issued its most serious warning for contaminated organic blueberries. Alma Pak International recalled 400 boxes (12,000 pounds) of berries after routine tests found Listeria monocytogenes, a deadly bacteria. The Georgia-based company shipped the tainted fruit to one customer in North Carolina before catching the problem in June. By July 1, the FDA declared this a "Class I recall" – meaning eating these berries could cause severe sickness or death. The risky blueberries carry lot numbers 13325 G1060 and 13325 G1096. Though the company claims no berries reached grocery stores, the FDA warns everyone to check their freezers and avoid these products completely. Listeria isn't just ordinary food poisoning. It's America's third-deadliest foodborne illness, killing about 260 people yearly. Unlike most bacteria, Listeria grows in refrigerators, making it extra sneaky. Healthy adults might suffer only fever, vomiting, or diarrhea for a few days. But for pregnant women, it can trigger miscarriages or stillbirths. Older adults, newborns, and people with weak immune systems can develop deadly meningitis (brain swelling) or sepsis. Warning signs include intense headaches, stiff necks, confusion, or seizures. If you ate these berries and feel ill, doctors urge immediate medical help, especially if pregnant. This recall comes just weeks after listeria-tainted chicken meals caused 3 deaths and a miscarriage nationwide. This blueberry alert fits a frightening pattern: US food recalls are skyrocketing. In 2024 alone, roughly 300 recalls made 1,400 people sick, hospitalized 487, and killed 19, double 2023's death toll. Recent months saw recalls for shrimp, turkey, and prepared meals like FreshRealm's fettuccine (sold at Kroger and Walmart). While blueberries normally offer health benefits like better blood pressure and reduced inflammation, contaminated ones become dangerous. Experts advise washing produce thoroughly, cleaning fridge surfaces monthly, and monitoring FDA recall updates. As one microbiologist notes: 'Listeria's early symptoms look like regular flu, but delaying treatment can be fatal when it attacks your brain.'
Time of India
12 hours ago
- Time of India
India's health survey data reveals 13% children born prematurely, 17% with low birth weight
New Delhi: India's demographic health survey 2019-21 reveals that 13 per cent of children were born prematurely, and 17 per cent with a low weight at birth, with air pollution contributing to the adverse birth outcomes . Researchers from the Indian Institute of Technology, Delhi, International Institute for Population Sciences, Mumbai, and institutes in the UK and Ireland looked at the National Family Health Survey-5 and remote sensing data to analyse how exposure to air pollution in pregnancy impacted the delivery outcomes. The team found that an increased exposure to PM2.5 during pregnancy was related with a 40 per cent chance of low birth weight, and 70 per cent of premature delivery. Climate conditions, such as rainfall and temperature, were found to have a greater link with adverse birth outcomes. The study, published in the journal PLoS Global Public Health, also found that children living in the northern districts of India could be more vulnerable to the ambient air pollution. Measuring under 2.5 microns in diameter, fine particulate matter 2.5 (PM2.5) is considered among the most harmful air pollutants, sources of which include burning of fossil fuels and biomass. The researchers found higher levels of PM2.5 pollutants over the upper Gangetic region, covering states like Uttar Pradesh, Bihar, Delhi, Punjab and Haryana, and lower levels in the country's southern and north-eastern regions. A higher prevalence of premature births was seen in northern states, such as Himachal Pradesh (39 per cent), Uttarakhand (27 per cent), Rajasthan (18 per cent), and Delhi (17 per cent). Mizoram, Manipur and Tripura exhibited a lower prevalence of the trend. Punjab was found to have the highest prevalence of lower birth weight at 22 per cent, followed by Delhi, Dadra and Nagar Haveli, Madhya Pradesh, Haryana, and Uttar Pradesh. North-east India fared far better on the metric, the authors said. "Utilising data from the national family health survey and raster images, the study employs various statistical analyses and spatial models to elucidate the connection between in-utero exposure to air pollution and birth outcomes," the authors wrote. They "observed that approximately 13 per cent of children were born prematurely, and 17 per cent were born with low birth weight." Further, an increase of 10 microgram per cubic metre in PM2.5 exposure was associated with an increase of five per cent in the prevalence of low birth weight, and 12 per cent in premature birth. The team added that 18 per cent of children born in the five years preceding the National Family Health Survey-5 had a low weight at birth. The authors called for targeted interventions, especially in the northern districts, and an intensification of the National Clean Air Program. Launched in 2019, the programme is aimed at improving air quality in India by addressing PM levels. The researchers also advocated for climate adaptation strategies, such as heat action plans and water management, to be included in public health planning. Awareness of risks due to air pollution and climate change should be raised as part of public health initiatives, especially among pregnant women, the team said.
NDTV
13 hours ago
- NDTV
13% Children Born Prematurely. 17% With Low Birth Weight In India: Report
New Delhi: India's demographic health survey 2019-21 reveals that 13 per cent of children were born prematurely, and 17 per cent with a low weight at birth, with air pollution contributing to the adverse birth outcomes. Researchers from the Indian Institute of Technology, Delhi, International Institute for Population Sciences, Mumbai, and institutes in the UK and Ireland looked at the National Family Health Survey-5 and remote sensing data to analyse how exposure to air pollution in pregnancy impacted the delivery outcomes. The team found that an increased exposure to PM2.5 during pregnancy was related with a 40 per cent chance of low birth weight, and 70 per cent of premature delivery. Climate conditions, such as rainfall and temperature, were found to have a greater link with adverse birth outcomes. The study, published in the journal PLoS Global Public Health, also found that children living in the northern districts of India could be more vulnerable to the ambient air pollution. Measuring under 2.5 microns in diameter, fine particulate matter 2.5 (PM2.5) is considered among the most harmful air pollutants, sources of which include burning of fossil fuels and biomass. The researchers found higher levels of PM2.5 pollutants over the upper Gangetic region, covering states like Uttar Pradesh, Bihar, Delhi, Punjab and Haryana, and lower levels in the country's southern and north-eastern regions. A higher prevalence of premature births was seen in northern states, such as Himachal Pradesh (39 per cent), Uttarakhand (27 per cent), Rajasthan (18 per cent), and Delhi (17 per cent). Mizoram, Manipur and Tripura exhibited a lower prevalence of the trend. Punjab was found to have the highest prevalence of lower birth weight at 22 per cent, followed by Delhi, Dadra and Nagar Haveli, Madhya Pradesh, Haryana, and Uttar Pradesh. North-east India fared far better on the metric, the authors said. "Utilising data from the national family health survey and raster images, the study employs various statistical analyses and spatial models to elucidate the connection between in-utero exposure to air pollution and birth outcomes," the authors wrote. They "observed that approximately 13 per cent of children were born prematurely, and 17 per cent were born with low birth weight." Further, an increase of 10 microgram per cubic metre in PM2.5 exposure was associated with an increase of five per cent in the prevalence of low birth weight, and 12 per cent in premature birth. The team added that 18 per cent of children born in the five years preceding the National Family Health Survey-5 had a low weight at birth. The authors called for targeted interventions, especially in the northern districts, and an intensification of the National Clean Air Program. Launched in 2019, the programme is aimed at improving air quality in India by addressing PM levels. The researchers also advocated for climate adaptation strategies, such as heat action plans and water management, to be included in public health planning. Awareness of risks due to air pollution and climate change should be raised as part of public health initiatives, especially among pregnant women, the team said.
